Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Introducing Emerging Science for the Clinician

Introducing Emerging Science for the Clinician Opinion EDITORIAL Michael S. Parmacek, MD A fundamental challenge faced by leaders in academic Wu and colleagues from Stanford highlighting the po- medicine is how to create an environment where clinicians tential application of cardiac stem cells in the treatment 1,2 interact with their colleagues engaged in basic, transla- of heart failure were among the most downloaded tional, and clinical research. Historically, the unique per- JAMA Cardiology articles. The editorial board believes that spective of specialists actively engaged in clinical practice there is pent-up demand for timely, well-written, but concise has served as a catalyst for reviews highlighting basic and translational discoveries that physician scientists and are likely to affect the practice of cardiology. With this goal in Related article page 914 clinical investigators pro- mind, the editorial board is pleased to announce a new moting medical discovery. feature of JAMA Cardiology entitled “Emerging Science for However, in a world where clinicians face ever-increasing the Clinician.” The goal of this quarterly feature is to provide focus on productivity metrics (relative value units), indirect the general readership of JAMA Cardiology with updates patient care (electronic patient portals), the electronic highlighting breakthrough science with particular focus health record, and regulatory demands, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Cardiology American Medical Association

Introducing Emerging Science for the Clinician

Parmacek, Michael S.
JAMA Cardiology , Volume 2 (8) – Aug 14, 2017
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/introducing-emerging-science-for-the-clinician-0Zsqz9fYuR
Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2380-6583
eISSN
2380-6591
DOI
10.1001/jamacardio.2017.1718
Publisher site
See Article on Publisher Site

Abstract

Opinion EDITORIAL Michael S. Parmacek, MD A fundamental challenge faced by leaders in academic Wu and colleagues from Stanford highlighting the po- medicine is how to create an environment where clinicians tential application of cardiac stem cells in the treatment 1,2 interact with their colleagues engaged in basic, transla- of heart failure were among the most downloaded tional, and clinical research. Historically, the unique per- JAMA Cardiology articles. The editorial board believes that spective of specialists actively engaged in clinical practice there is pent-up demand for timely, well-written, but concise has served as a catalyst for reviews highlighting basic and translational discoveries that physician scientists and are likely to affect the practice of cardiology. With this goal in Related article page 914 clinical investigators pro- mind, the editorial board is pleased to announce a new moting medical discovery. feature of JAMA Cardiology entitled “Emerging Science for However, in a world where clinicians face ever-increasing the Clinician.” The goal of this quarterly feature is to provide focus on productivity metrics (relative value units), indirect the general readership of JAMA Cardiology with updates patient care (electronic patient portals), the electronic highlighting breakthrough science with particular focus health record, and regulatory demands,

Journal

JAMA Cardiology – American Medical Association

Published: Aug 14, 2017

References

  • Adult stem cell therapy and heart failure, 2000 to 2016: a systematic review
    Nguyen, PK; Rhee, JW; Wu, JC
  • Potential strategies to address the major clinical barriers facing stem cell regenerative therapy for cardiovascular disease: a review
    Nguyen, PK; Neofytou, E; Rhee, JW; Wu, JC
  • The hope and hype of CRISPR-Cas9 genome editing
    Musunuru, K